OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
-11.21%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$154M
AUM Growth
+$154M
(-3.6%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
10.52%
Top 10 Holdings %
Top 10 Hldgs %
99.79%
Holding
12
New
1
Increased
–
Reduced
3
Closed
–
Top Buys
| 1 |
UPB
Upstream Bio, Inc. Common Stock
UPB
|
$33.5M |
Top Sells
| 1 |
Lexeo Therapeutics
LXEO
|
$7.71M |
| 2 |
Replimune Group
REPL
|
$5.89M |
| 3 |
enGene Holdings
ENGN
|
$3.66M |
Sector Composition
| 1 | Healthcare | 99.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCAX
1
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $38.4M | 24.91% | 2,204,650 | – | – |
|
2
Nuvation Bio
NUVB
$1.02B
| $34.8M | 22.55% | 13,072,340 | – | – |
|
|
UPB
3
Upstream Bio, Inc. Common Stock
UPB
$923M
| $33.5M | 21.71% | +2,036,293 | New | +$33.5M |
|
|
4
Replimune Group
REPL
$422M
| $23.9M | 15.51% | 1,975,203 -486,116 | -20% | -$5.89M |
|
|
5
Lexeo Therapeutics
LXEO
$259M
| $7.79M | 5.06% | 1,184,636 -1,171,268 | -50% | -$7.71M |
|
|
ALMS
6
Alumis Inc. Common Stock
ALMS
$479M
| $5.13M | 3.33% | 653,223 | – | – |
|
|
IMA
7
ImageneBio, Inc. Common Stock
IMA
$150M
| $3.69M | 2.39% | 2,249,123 | – | – |
|
|
8
enGene Holdings
ENGN
$236M
| $3.5M | 2.27% | 526,357 -550,000 | -51% | -$3.66M |
|
9
Immunic
IMUX
$80.9M
| $1.79M | 1.16% | 1,788,160 | – | – |
|
10
Sana Biotechnology
SANA
$777M
| $1.38M | 0.89% | 843,750 | – | – |
|
|
11
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $271K | 0.18% | 321,502 | – | – |
|
|
SYRS
12
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $57.8K | 0.04% | 251,270 | – | – |
|